➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
Dow
McKinsey
Johnson and Johnson

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

NITROGLYCERIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Nitroglycerin, and what generic alternatives are available?

Nitroglycerin is a drug marketed by Hercon Pharm, Lannett Co Inc, Mylan Technologies, Abraxis Pharm, Am Regent, Hospira, Intl Medication, Luitpold, Smith And Nephew, Fougera Pharms Inc, Perrigo Israel, Actavis Labs Fl Inc, Alvogen, Dr Reddys, Glenmark Pharms Sa, Rubicon, Sigmapharm Labs Llc, and Baxter Hlthcare. and is included in twenty-seven NDAs.

The generic ingredient in NITROGLYCERIN is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nitroglycerin

A generic version of NITROGLYCERIN was approved as nitroglycerin by AM REGENT on May 24th, 1988.

  Free Forever Trial

Drug patent expirations by year for NITROGLYCERIN
Drug Prices for NITROGLYCERIN

See drug prices for NITROGLYCERIN

Drug Sales Revenue Trends for NITROGLYCERIN

See drug sales revenues for NITROGLYCERIN

Recent Clinical Trials for NITROGLYCERIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Inonu UniversityN/A
Komar University of Science and TechnologyPhase 1/Phase 2
Aristotle University Of ThessalonikiPhase 3

See all NITROGLYCERIN clinical trials

Pharmacology for NITROGLYCERIN
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for NITROGLYCERIN
Paragraph IV (Patent) Challenges for NITROGLYCERIN
Tradename Dosage Ingredient NDA Submissiondate
NITROLINGUAL AEROSOL;SUBLINGUAL nitroglycerin 018705 2012-04-17
NITROLINGUAL PUMPSPRAY SPRAY, METERED;SUBLINGUAL nitroglycerin 018705 2012-04-17
NITROSTAT TABLET;SUBLINGUAL nitroglycerin 021134 2005-10-19
NITRO-DUR FILM, EXTENDED RELEASE;TRANSDERMAL nitroglycerin 020145
TRANSDERM-NITRO FILM, EXTENDED RELEASE;TRANSDERMAL nitroglycerin 020144

US Patents and Regulatory Information for NITROGLYCERIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sigmapharm Labs Llc NITROGLYCERIN nitroglycerin TABLET;SUBLINGUAL 207745-002 May 7, 2018 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Dr Reddys NITROGLYCERIN nitroglycerin TABLET;SUBLINGUAL 208191-002 Aug 26, 2016 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Hospira NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 071848-001 Aug 31, 1990 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 019970-003 Dec 29, 1989 AP RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Alvogen NITROGLYCERIN nitroglycerin TABLET;SUBLINGUAL 211604-001 Apr 30, 2019 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Dr Reddys NITROGLYCERIN nitroglycerin TABLET;SUBLINGUAL 208191-003 Aug 26, 2016 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Alvogen NITROGLYCERIN nitroglycerin TABLET;SUBLINGUAL 211604-002 Apr 30, 2019 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
Dow
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.